De Novo device
VasQ
Laminate Medical Technologies · Extravascular Support For An Arteriovenous Fistula For Vascular Access (QVQ, Class II) · First FDA decision Sep 26, 2023, newest Oct 29, 2026Kidney failure and dialysisVascular access
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
Breakthrough-designated
Device trials
5
Naming "VasQ"
MAUDE reports
0
Brand "VasQ", since 2015
PubMed studies
38
Mentioning "VasQ"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing VasQ
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- VasQ510(k)
K263598 · Decided Oct 29, 2026 · 29 days after receipt
Device type: Extravascular Support For An Arteriovenous Fistula For Vascular Access (QVQ) · Cardiology
- VasQ510(k)
K240119 · Decided Feb 16, 2024 · 31 days after receipt
Device type: Extravascular Support For An Arteriovenous Fistula For Vascular Access (QVQ) · Cardiology
- VasQNew device typeBreakthroughDe Novo
DEN220026 · Decided Sep 26, 2023 · 515 days after receipt
Device type: Extravascular Support For An Arteriovenous Fistula For Vascular Access (QVQ) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Non-Invasive Peripheral Venous Vascular and Hemodialysis Access StudiesLocal determinationIn effectL35751WPS Insurance CorporationUpdated Feb 20, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "VasQ", any status and sponsor, newest update first.
- Post Market Study for VasQ, an External Support Implant for Arteriovenous FistulaPivotal-lookingRecruiting
Laminate Medical TechnologiesNot on our public-company list
NCT06516653 · 300 participants (planned) · Start Jan 13, 2025 · Primary completion Aug 2027
Device: VasQ · For: End Stage Renal Disease
Sites: Long Beach, California; Sarasota, Florida; Atlanta, Georgia · 13 sites in all
Laminate Medical TechnologiesNot on our public-company list
NCT03242343 · 144 participants · Start Nov 29, 2017 · Primary completion Oct 8, 2020
Device: VasQ · For: Arterio-Venous Fistula; ESRD; Steal Syndrome and 5 more
Sites: Birmingham, Alabama; Phoenix, Arizona; Peoria, Illinois · 15 sites in all
Laminate Medical TechnologiesNot on our public-company list
NCT03246984 · 80 participants · Start Sep 7, 2017 · Primary completion Jan 11, 2021
Device: VasQ · For: Arterio-Venous Fistula; Kidney Failure, Chronic; Kidney Diseases and 3 more
Sites: Paris, France; Augsburg, Germany; Berlin, Germany · 11 sites in all
2 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "VasQ", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QVQ
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "VasQ"[tiab]. The summary above synthesizes these.
- Hemodynamic impact of VASQ device in vascular access creation.
Palumbo R, Dominijanni S, Centi A, et al. · J Vasc Access · 2022
- VasQ U.S. pivotal study demonstrates the safety and effectiveness of an external vascular support for arteriovenous fistula creation.
Dillavou ED, Lucas JF, Woodside K, et al. · J Vasc Surg · 2023Multicenter Study, Clinical Trial
- An Implanted Blood Vessel Support Device for Arteriovenous Fistulas: A Randomized Controlled Trial.
Karydis N, Bevis P, Beckitt T, et al. · Am J Kidney Dis · 2020Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- Initial single-center experience with a new external support device for the creation of the forearm native arteriovenous fistula for hemodialysis.
Benedetto F, Spinelli D, Derone G, et al. · J Vasc Access · 2022
- Arteriovenous fistula creation with VasQTM device: A feasibility study to reveal hemodynamic implications.
Bozzetto M, Soliveri L, Poloni S, et al. · J Vasc Access · 2024Randomized Controlled Trial
- Achieving high maturation and cannulation rates of radial-cephalic arteriovenous fistulas with VasQࡊ device.
Shahverdyan R, Hentschel DM · Semin Dial · 2023
- How Should We Assess Pain: Do Patients Prefer a Quantitative or Qualitative Scale? A Study of Patient Preferences.
Firdous S, Berger A, Jehangir W, et al. · Am J Hosp Palliat Care · 2021
- Efficacy and safety of implantable vascular support in the treatment of arteriovenous fistula: A single-arm meta-analyses.
Li X, Ma C, Li W, et al. · J Vasc Access · 2025Meta-Analysis, Systematic Review
- Is the VasQࡊ device useful in the maturation of native arteriovenous fistulas? A single-center experience.
Fontseré N, Mestres G, Yugueros X, et al. · Nefrologia (Engl Ed) · 2024Letter
- Insecure attachment style as a vulnerability factor for depression: recent findings in a community-based study of Malay single and married mothers.
Abdul Kadir NB, Bifulco A · Psychiatry Res · 2013Research Support, Non-U.S. Gov't
- Implanted blood vessel external support device (VasQࡊ) for creation of hemodialysis arteriovenous fistula: A single-center experience.
Leonardi G, Campagna M, Pellicanò V, et al. · J Vasc Access · 2021
- Multicenter European real-world utilization of VasQ anastomotic external support device for arteriovenous fistulae.
Shahverdyan R, Tabbi P, Mestres G · J Vasc Surg · 2022Multicenter Study
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.